API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.
In 2023, our API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.
In 2023, our API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.